May 07, 2024 7:45am EDT Sigyn Therapeutics™ Discloses Publication of “Sigyn TherapyTM, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections.”
Dec 12, 2023 8:30am EST Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer
Oct 04, 2023 8:30am EDT Sigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity
